Healthcare & Life Sciences
Graegis Pharmaceuticals
United Kingdomgraegis.com
Graegis Pharmaceuticals is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Graegis Pharmaceuticals
Graegis Pharmaceuticals is a startup based in the United Kingdom. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Graegis Pharmaceuticals develops topical therapies using reactive oxygen species scavengers to prevent and manage radiation-induced dermatitis and oral mucositis in cancer patients undergoing radiotherapy.
Explore Graegis Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.